Literature DB >> 22024827

Genetic environment and stability of cfr in methicillin-resistant Staphylococcus aureus CM05.

Jeffrey B Locke1, Shahad Rahawi, Jacqueline Lamarre, Alexander S Mankin, Karen Joy Shaw.   

Abstract

The Cfr methyltransferase confers resistance to many 50S ribosomal subunit-targeted antibiotics, including linezolid (LZD), via methylation of the 23S rRNA base A2503 in the peptidyl transferase center. Methicillin-resistant Staphylococcus aureus strain CM05 is the first clinical isolate documented to carry cfr. While cfr is typically plasmid borne, in CM05 it is located on the chromosome and is coexpressed with ermB as part of the mlr operon. Here we evaluated the chromosomal locus, association with mobile genetic elements, and stability of the cfr insertion region in CM05. The cfr-containing mlr operon is located within a 15.5-kb plasmid-like insertion into 23S rRNA allele 4. The region surrounding the cfr gene has a high degree of sequence similarity to the broad-host-range toxin/antitoxin multidrug resistance plasmid pSM19035, including a second ermB gene downstream of the mlr locus and istAS-istBS. Analysis of several individual CM05 colonies revealed two distinct populations for which LZD MICs were either 8 or 2 μg/ml. In the LZD(s) colonies (designated CM05Δ), a recombination event involving the two ermB genes had occurred, resulting in the deletion of cfr and the 3' flanking region (cfr-istAS-istBS-ermB). The fitness advantage of CM05Δ over CM05 (though not likely due to the cfr deletion itself) results in the predominance of CM05Δ in the absence of selective pressure. Minicircles resulting from the ermB recombination event and the novel association of cfr with the pSM19035 plasmid system support the potential for the continued dissemination of cfr.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024827      PMCID: PMC3256036          DOI: 10.1128/AAC.05420-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  52 in total

1.  Single-primer PCR procedure for rapid identification of transposon insertion sites.

Authors:  A V Karlyshev; M J Pallen; B W Wren
Journal:  Biotechniques       Date:  2000-06       Impact factor: 1.993

2.  Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides.

Authors:  Anne-Laure Prunier; Brigitte Malbruny; Didier Tandé; Bertrand Picard; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

3.  Comparative DNA analysis of two vanA plasmids from Enterococcus faecium strains isolated from poultry and a poultry farmer in Norway.

Authors:  H Sletvold; P J Johnsen; G S Simonsen; B Aasnaes; A Sundsfjord; K M Nielsen
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  A sequencing method based on real-time pyrophosphate.

Authors:  M Ronaghi; M Uhlén; P Nyrén
Journal:  Science       Date:  1998-07-17       Impact factor: 47.728

5.  Evaluation of Alamar colorimetric broth microdilution susceptibility testing method for staphylococci and enterococci.

Authors:  C N Baker; F C Tenover
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

6.  Low fitness cost of the multidrug resistance gene cfr.

Authors:  Jacqueline M LaMarre; Jeffrey B Locke; Karen J Shaw; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

7.  Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates.

Authors:  Corinna Kehrenberg; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

8.  The Bacillus subtilis histone-like protein Hbsu is required for DNA resolution and DNA inversion mediated by the beta recombinase of plasmid pSM19035.

Authors:  J C Alonso; F Weise; F Rojo
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

9.  Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.

Authors:  Ronald N Jones; James E Ross; Jan M Bell; Uchino Utsuki; Ikeda Fumiaki; Intetsu Kobayashi; John D Turnidge
Journal:  Diagn Microbiol Infect Dis       Date:  2009-12       Impact factor: 2.803

10.  Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.

Authors:  Jeffrey B Locke; Mark Hilgers; Karen Joy Shaw
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

View more
  27 in total

1.  Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene.

Authors:  Jeffrey B Locke; Douglas E Zuill; Caitlyn R Scharn; Jennifer Deane; Daniel F Sahm; Gerald A Denys; Richard V Goering; Karen J Shaw
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  Streptococcus pneumoniae transposon Tn1545/Tn6003 changes to Tn6002 due to spontaneous excision in circular form of the erm(B)- and aphA3-containing macrolide-aminoglycoside-streptothricin (MAS) element.

Authors:  Claudio Palmieri; Marina Mingoia; Orietta Massidda; Eleonora Giovanetti; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

3.  First report of the multidrug resistance gene cfr in Enterococcus faecalis of animal origin.

Authors:  Yang Liu; Yang Wang; Congming Wu; Zhangqi Shen; Stefan Schwarz; Xiang-Dang Du; Lei Dai; Wanjiang Zhang; Qijing Zhang; Jianzhong Shen
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

4.  The genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147L.

Authors:  Jacqueline LaMarre; Rodrigo E Mendes; Teresa Szal; Stefan Schwarz; Ronald N Jones; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

Review 5.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

6.  Unconventional circularizable bacterial genetic structures carrying antibiotic resistance determinants.

Authors:  Claudio Palmieri; Marina Mingoia; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2013-05       Impact factor: 5.191

7.  Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.

Authors:  Jamese J Hilliard; Vivekananda Datta; Christine Tkaczyk; Melissa Hamilton; Agnieszka Sadowska; Omari Jones-Nelson; Terrence O'Day; William J Weiss; Szabolcs Szarka; Vien Nguyen; Laszlo Prokai; JoAnn Suzich; C Kendall Stover; Bret R Sellman
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

8.  Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus.

Authors:  Lorena Diaz; Dimitrios P Kontoyiannis; Diana Panesso; Nathaniel D Albert; Kavindra V Singh; Truc T Tran; Jose M Munita; Barbara E Murray; Cesar A Arias
Journal:  J Infect Dis       Date:  2013-04-01       Impact factor: 5.226

9.  Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil.

Authors:  Lara M Almeida; François Lebreton; Anthony Gaca; Paulo M Bispo; Jose T Saavedra; Rodrigo N Calumby; Luciano M Grillo; Ticiano G Nascimento; Pedro H Filsner; Andrea M Moreno; Michael S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

10.  Identification and characterization of linezolid-resistant cfr-positive Staphylococcus aureus USA300 isolates from a New York City medical center.

Authors:  Jeffrey B Locke; Douglas E Zuill; Caitlyn R Scharn; Jennifer Deane; Daniel F Sahm; Richard V Goering; Stephen G Jenkins; Karen J Shaw
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.